5-Amino-3-(Trifluoromethyl) picolinonitrile CAS 573762-62-6 Apalutamide intermedia Puritas
Shanghai Ruifu Chemical Co., Ltd. est primarium fabrica 5-Amino-3-(Trifluoromethyl)picolinonitrile (CAS: 573762-62-6) cum qualitate media Apalutamide (CAS: 956104-40-8).Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Apalutamide Intermedia,Please contact: alvin@ruifuchem.com
| Nomen chemicum | 5-Amino-3-(Trifluoromethyl) picolinonitrile |
| Synonyma | 5-Amino-3-(Trifluoromethyl) pyridine-2-Carbonitrile;5-Amino-3-(Trifluoromethyl) 2-Cyanopyridine;5-Amino-2-Cyano-3-(Trifluoromethyl) pyridine;Apalutamide immunditia 10 |
| Stock Status | In Stock, Commercial Productio |
| CAS Number | 573762-62-6 |
| Formulae hypotheticae | C7H4F3N3 |
| M. Pondus | 187.12 g/mol |
| Density | 1.45±0.10 g/cm3 |
| COA & MSDS | Praesto |
| Origin | Shanghai, China |
| Periculum Classis | 6.1 |
| Stipare Group | Ⅲ |
| Categoria | Medium Apalutamidis (CAS: 956104-40-8) |
| Brand | Ruifu Chemical |
| Items | Signa inspectionis | Proventus |
| Aspectus | Lux Yellow ad Yellow solidus | Obsequitur |
| Aquae Caroli Fischer | <0.50% | 0.35% |
| Puritas / Analysis Methodus | >98.0% (HPLC) | 99.03% |
| Infrared Imaginis | Congruunt Structure | Obsequitur |
| 1H NMR Imaginum | Congruunt Structure | Obsequitur |
| conclusio | Productum probatum est et cum datis specificationibus obsequitur | |
| Applicationem | Medium Apalutamidis (CAS: 956104-40-8) | |
Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in frigido, sicco et bene ventilato horreis a substantiis incompossibilibus repone.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
5-Amino-3-(Trifluoromethyl) picolinonitrile (CAS: 573762-62-6) est compositio organica pyridine heterocyclica, quae uti intermediis pharmaceuticis adhiberi potest.5-Amino-3-(Trifluoromethyl) picolinonitrile est medium Apalutamide (CAS: 956104-40-8).Apalutamide secunda generatio est antiandrogen in curatione cancer prostatae.Est potentis antagonista receptoris androgeni cum valore IC50 16 nm.Receptores androgen ligant, ita inhibent translocationem nuclei, DNA ligationem et activationem transcriptionem.Apalutamide applicationes therapeuticas in cancro prostate prostatae non metastatico castrationis repugnante habet.
Apalutamide quaedam genera cancri prostati resistentis vel prostatae cancri castrationis tractare adhibetur, quae ad alias partes corporis non pervasit, sed ab aliis medicinis curationibus adiutus non est.Apalutamide est in genere medicamenti receptor inhibitores androgen vocati.Operatur effectum androgenium impedire, ut incrementum et propagationem cellularum cancri sistit.Die 17 Septembris 2019, Cibus et medicamentum Administrationis Apalutamide approbavit (ERLEADA, Janssen Biotech, Inc) aegris metastatico-castratione sensitivo cancer prostatae (mCSPC).Apalutamide initio anno 2018 probatus est aegris cum cancer prostatae castrationis non metastaticae repugnans.
